Page last updated: 2024-09-05

dofequidar and elacridar

dofequidar has been researched along with elacridar in 1 studies

Compound Research Comparison

Studies
(dofequidar)
Trials
(dofequidar)
Recent Studies (post-2010)
(dofequidar)
Studies
(elacridar)
Trials
(elacridar)
Recent Studies (post-2010) (elacridar)
40252848119

Protein Interaction Comparison

ProteinTaxonomydofequidar (IC50)elacridar (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)0.4427
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.2852

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ford, PJ; Germann, UA; Harding, MW; Mason, VS; Shlyakhter, D1

Other Studies

1 other study(ies) available for dofequidar and elacridar

ArticleYear
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
    Anti-cancer drugs, 1997, Volume: 8, Issue:2

    Topics: Acridines; Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; HL-60 Cells; Humans; Isoquinolines; Multidrug Resistance-Associated Proteins; Piperidines; Pyridines; Quinolines; Tetrahydroisoquinolines; Tritium; Verapamil; Vincristine

1997